Pharmacist Provider Status Bill Reintroduced in House
Wed, 28 Jan 2015 00:00:00 -0500
A bipartisan group of legislators in the House of Representatives has reintroduced a bill to have the Medicare program cover state-authorized pharmacist services, the lawmakers jointly announced today.
FDA Approves Meningitis B Vaccine
Mon, 26 Jan 2015 00:00:00 -0500
FDA on January 23 announced the approval of Bexsero, a Novartis vaccine that protects against invasive meningococcal disease caused by Neisseria meningitidis serogroup B bacteria.
Not All Discounts on Certain Cancer Drugs Have Disappeared
Genentech continues to provide discounts on community physicians' purchases of bevacizumab, rituximab, and trastuzumab through company-authorized specialty distributors, according to a confidential document given to ASHP, as nonfederal hospitals and clinics cope with the new distribution model.
Study Finds Antimicrobial Prescribing at Discharge Rife With Errors
Pharmacists on a hospital's antimicrobial stewardship team say that medication errors at discharge that are related to antiinfective prescribing and use are surprisingly common and present an opportunity to improve transitional care.
Recombinant Hormone Approved as Add-On in Hypoparathyroidism Management
FDA and NPS Pharmaceuticals Inc. on January 23 announced the approval of parathyroid hormone, or Natpara, as add-on therapy in patients with hypoparathyroidism whose hypocalcemia cannot be well controlled with only calcium supplements and active forms of vitamin D.